Integra LifeSciences Featured in Forbes 2009 List of 200 Best Small Companies

Related Quotes

Symbol	Price	Change
IART	37.48	0.00

{"s" : "iart","k" : "c10,l10,p20,t10","o" : "","j" : ""}

PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART - News), a world leader in regenerative medicine, announced today that it has made Forbes magazine's 2009 list of "200 Best Small Companies."

"We're honored to have been named to Forbes 200 Best Small Companies for the fifth time in our history," said Stuart Essig, Integra's President and CEO. "Our success is due to the dedication of our employees who, since Integra's founding 20 years ago, have helped the company grow into a leader in developing medical devices, particularly for neurosurgery, spinal surgery and extremity reconstruction. We also have one of the largest surgical instrument companies in the United States. We look forward to continuing to grow our business and provide life-saving devices for patients around the world."

The Forbes 200 Best Small Companies ranking is limited to companies with sales between $5 million and $750 million and a stock price no lower than $5. A company's ranking is based on return on equity, sales growth, and profit growth over the past 12 months and over five years. Forbes also compares a company's stock performance with that of its industry peers.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients each year. The company's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world.

IART-G

Integra LifeSciences Holdings Corporation
Gianna Sabella, Director of Corporate Communications
(609) 936-2389
gsabella@integra-LS.com